Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/29/16 → 03/8/23 |
Funding
- Alkermes Incorporated: $81,444.25
A Phase 3 Open Label Study to Evaluate the Long-Term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
Project: Research